Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations segments. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other products and services to insured and self-insured customers. This segment also provides Medicare Advantage and Medicare Part D plans to seniors, and Medicaid plans. The Global Supplemental Benefits segment offers supplemental health, life, and accident insurance products. The Group Disability and Life segment provides group long-term and short-term disability, group life, accident, and specialty insurance products and related services. The Other Operations segment offers corporate-owned life insurance products that are permanent insurance contracts sold to corporations to provide coverage; and run-off settlement annuity contracts. The company distributes its products and services through insurance brokers and insurance consultants; and directly to employers, unions and other groups, or individuals, as well as through direct response television and the Internet. Cigna Corporation was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Industry, Sector and Symbol
Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorFinance
SymbolNYSE:CI
CUSIP12550910
Phone860-226-6000
Debt
Debt-to-Equity Ratio0.38%
Current Ratio0.37%
Quick Ratio0.37%
Price-To-Earnings
Trailing P/E Ratio16.25
Forward P/E Ratio13.18
P/E Growth1.02
Sales & Book Value
Annual Sales$41.62 billion
Price / Sales0.99
Cash Flow$13.1127 per share
Price / Cash12.96
Book Value$55.71 per share
Price / Book3.05
Profitability
EPS (Most Recent Fiscal Year)$10.46
Net Income$2.24 billion
Net Margins5.38%
Return on Equity18.84%
Return on Assets4.33%
Miscellaneous
Employees46,000
Outstanding Shares242,880,000
Cigna (NYSE:CI) Frequently Asked Questions
What is Cigna's stock symbol?
Cigna trades on the New York Stock Exchange (NYSE) under the ticker symbol "CI."
How often does Cigna pay dividends? What is the dividend yield for Cigna?
Cigna declared a quarterly dividend on Wednesday, February 28th. Stockholders of record on Monday, March 12th will be paid a dividend of $0.04 per share on Tuesday, April 10th. This represents a $0.16 annualized dividend and a dividend yield of 0.09%. The ex-dividend date of this dividend is Friday, March 9th. View Cigna's Dividend History.
How will Cigna's stock buyback program work?
Cigna announced that its board has approved a share repurchase plan on Sunday, June 4th 2017, which permits the company to buyback $3,700,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to purchase up to 9.8% of its shares through open market purchases. Shares buyback plans are typically a sign that the company's board believes its stock is undervalued.
How were Cigna's earnings last quarter?
Cigna (NYSE:CI) posted its earnings results on Thursday, February, 1st. The health services provider reported $1.94 EPS for the quarter, topping the Zacks' consensus estimate of $1.87 by $0.07. The health services provider earned $10.53 billion during the quarter, compared to analysts' expectations of $10.28 billion. Cigna had a net margin of 5.38% and a return on equity of 18.84%. The firm's revenue for the quarter was up 5.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.87 EPS. View Cigna's Earnings History.
When is Cigna's next earnings date?
What guidance has Cigna issued on next quarter's earnings?
Cigna issued an update on its FY18 earnings guidance on Thursday, February, 1st. The company provided earnings per share guidance of $12.40-12.90 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $12.18. The company issued revenue guidance of +7-8% to ~$44.53-44.95 billion, compared to the consensus revenue estimate of $43.87 billion.
What price target have analysts set for CI?
18 Wall Street analysts have issued twelve-month target prices for Cigna's shares. Their predictions range from $174.00 to $255.00. On average, they anticipate Cigna's stock price to reach $209.2222 in the next year. View Analyst Ratings for Cigna.
What are Wall Street analysts saying about Cigna stock?
Here are some recent quotes from research analysts about Cigna stock:
- 1. According to Zacks Investment Research, "Cigna’s shares have underperformed the industry in a year. The company has been witnessing increase in leverage. Suspension of share buyback and huge execution risk related to the recent deal are some of the major concerns. Its Medicare business is also expected to remain under pressure. The company has also received negative rating action from the rating agencies. However, the company is on track to buy Express Scripts, which should raise its rank in the health insurance industry and equip it better to face stiff competition. Synergies from the acquisition should buoy the company's long-term growth potential. Its robust Global Supplemental business, growing Government business and increasing membership, and strong capital position are the other positives. A strong outlook for 2018 reflects its business strength. Moreover, it has seen the Zacks Consensus Estimate for 2018 earnings being revised upward in the last 30 days." (4/16/2018)
- 2. Jefferies Group LLC analysts commented, "CI reported Q2:17 adjusted EPS of $2.91 (GAAP $3.15), compared to OPCO’s estimate of $2.46 and Street consensus of $2.45. Adjusted results exclude $0.13 of realized investment gains and $0.18 from merger-related tax benefits, offset by $0.07 of amortization expense. The beat was driven by the Healthcare segment, with the Commercial MCR of 78.7% outperforming OPCO/Street estimates by 200/160 bps. Due to the beat, the company raised FY2017 EPS guidance to $9.75-$10.05 vs. $9.35-$9.85, with all three segment outlooks growing by $15-$40M." (8/4/2017)
Who are some of Cigna's key competitors?
Some companies that are related to Cigna include Australia and New Zealand Banking Group (ANZ), National Australia Bank (NAB), China Life Insurance (LFC), Industrial and Commercial Bank of China (IDCBY), Charles Schwab (SCHW), Banco Bradesco (BBD), Westpac (WBK), Scotiabank (BNS), AXA (AXAHY), ING Groep (ING), UBS (UBS), Prudential (PUK), PNC Financial Services Group (PNC), Lloyds Banking Group (LYG), Bank of Montreal (BMO), Chubb (CB), Altaba (AABA) and Powershares QQQ Trust Series 1 (QQQ).
Who are Cigna's key executives?
Cigna's management team includes the folowing people:
- Mr. David Michael Cordani, CEO, Pres & Director (Age 53)
- Ms. Nicole Susan Jones, Exec. VP & Gen. Counsel (Age 47)
- Mr. Jason D. Sadler, Pres of International Markets (Age 49)
- Mr. Eric Paul Palmer, Exec. VP & CFO (Age 41)
- Ms. Mary Terese Agoglia Hoeltzel CPA, VP & Chief Accounting Officer
Has Cigna been receiving favorable news coverage?
News articles about CI stock have been trending somewhat positive on Sunday, according to Accern Sentiment Analysis. The research firm identifies positive and negative press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Cigna earned a news impact score of 0.18 on Accern's scale. They also gave media stories about the health services provider an impact score of 46.54 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the near term.
How do I buy shares of Cigna?
Shares of CI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Cigna's stock price today?
One share of CI stock can currently be purchased for approximately $169.94.
How big of a company is Cigna?
Cigna has a market capitalization of $41.27 billion and generates $41.62 billion in revenue each year. The health services provider earns $2.24 billion in net income (profit) each year or $10.46 on an earnings per share basis. Cigna employs 46,000 workers across the globe.
How can I contact Cigna?
Cigna's mailing address is 900 COTTAGE GROVE ROAD, BLOOMFIELD CT, 06002. The health services provider can be reached via phone at 860-226-6000 or via email at [email protected]
MarketBeat Community Rating for Cigna (CI)
MarketBeat's community ratings are surveys of what our community members think about Cigna and other stocks. Vote "Outperform" if you believe CI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CI will underperform the S&P 500 over the long term. You may vote once every thirty days.
Cigna (NYSE:CI) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
18 Wall Street analysts have issued ratings and price targets for Cigna in the last 12 months. Their average twelve-month price target is $209.2222, suggesting that the stock has a possible upside of 23.12%. The high price target for CI is $255.00 and the low price target for CI is $174.00. There are currently 4 hold ratings and 14 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 2.78 | 2.78 | 2.81 | 2.87 |
| Ratings Breakdown: | 0 Sell Rating(s)
4 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
4 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
3 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
2 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $209.2222 | $209.2222 | $203.5625 | $192.0667 |
| Price Target Upside: | 23.12% upside | 25.05% upside | 0.49% upside | 3.83% upside |
Cigna (NYSE:CI) Consensus Price Target History
Cigna (NYSE:CI) Analyst Ratings History
Show:
(Data available from 4/22/2016 forward)
Cigna (NYSE:CI) Dividend Information
Cigna pays an annual dividend of $0.04 per share, with a dividend yield of 0.02%. CI's most recent quarterly dividend payment was Tuesday, April 10. Cigna pays out 0.38% of its earnings out as a dividend.
| Most Recent Dividend: | 4/10/2018 |
| Annual Dividend: | $0.04 |
| Dividend Yield: | 0.02% |
| Dividend Growth: | 0.00% (3 Year Average) |
| Payout Ratio: | 0.38% (Trailing 12 Months of Earnings)
0.31% (Based on This Year's Estimates)
0.28% (Based on Next Year's Estimates)
|
Cigna (NYSE:CI) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 2/28/2018 | quarterly | $0.04 | 0.1% | 3/9/2018 | 3/12/2018 | 4/10/2018 |
| 2/22/2017 | quarterly | $0.04 | 0.03% | 3/8/2017 | 3/10/2017 | 4/10/2017 |
| 2/25/2016 | annual | $0.04 | 0.03% | 3/9/2016 | 3/11/2016 | 4/11/2016 |
| 2/26/2015 | annual | $0.04 | 0.03% | 3/10/2015 | 3/12/2015 | 4/10/2015 |
| 2/26/2014 | quarterly | $0.04 | 0.05% | 3/10/2014 | 3/12/2014 | 4/9/2014 |
| 3/1/2013 | annual | $0.04 | 0.07% | 3/8/2013 | 3/12/2013 | 4/10/2013 |
| 2/28/2013 | quarterly | $0.04 | | | 3/12/2013 | 4/10/2013 |
(Data available from 1/1/2013 forward)
Cigna (NYSE CI) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 1.10%
Institutional Ownership Percentage: 88.80%
Cigna (NYSE CI) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 3/5/2018 | Christopher J Hocevar | Insider | Sell | 2,759 | $191.84 | $529,286.56 | 12,784 |  |
| 3/5/2018 | David Cordani | CEO | Sell | 36,769 | $191.68 | $7,047,881.92 | 372,076 | |
| 3/5/2018 | Nicole S Jones | EVP | Sell | 5,856 | $190.68 | $1,116,622.08 | 36,658 | |
| 1/18/2018 | John M Murabito | EVP | Sell | 6,099 | $220.10 | $1,342,389.90 | 68,026 | |
| 1/16/2018 | Donna F. Zarcone | Director | Sell | 5,971 | $215.43 | $1,286,332.53 | | |
| 1/12/2018 | Jane E. Md Henney | Director | Sell | 400 | $212.96 | $85,184.00 | | |
| 1/10/2018 | John M Murabito | EVP | Sell | 28,037 | $205.68 | $5,766,650.16 | 60,290 | |
| 1/10/2018 | William D Zollars | Director | Sell | 212 | $205.68 | $43,604.16 | 13,500 | |
| 12/11/2017 | Isaiah Harris, Jr. | Chairman | Sell | 212 | $209.35 | $44,382.20 | | |
| 11/27/2017 | Alan Muney | EVP | Sell | 15,345 | $200.80 | $3,081,276.00 | 28,457 | |
| 11/27/2017 | Christopher J Hocevar | Insider | Sell | 8,387 | $200.32 | $1,680,083.84 | 12,363 | |
| 11/13/2017 | Michael W Triplett | Insider | Sell | 10,417 | $197.77 | $2,060,170.09 | 32,347 | |
| 11/9/2017 | Mary T Hoeltzel | CAO | Sell | 575 | $197.03 | $113,292.25 | 2,499 | |
| 9/13/2017 | William D. Zollars | Director | Sell | 1,232 | $187.23 | $230,667.36 | | |
| 9/12/2017 | Isaiah Harris, Jr. | Chairman | Sell | 247 | $185.27 | $45,761.69 | | |
| 8/16/2017 | Lisa R Bacus | EVP | Sell | 2,236 | $179.95 | $402,368.20 | 18,501 | |
| 8/9/2017 | Mary T Hoeltzel | VP | Sell | 525 | $177.59 | $93,234.75 | 1,924 | |
| 8/8/2017 | Michael W Triplett | Insider | Sell | 3,700 | $174.96 | $647,352.00 | 21,060 | |
| 8/7/2017 | Jason D Sadler | Insider | Sell | 37,756 | $176.16 | $6,651,096.96 | 47,844 | |
| 7/24/2017 | Jane E. Md Henney | Director | Sell | 600 | $174.14 | $104,484.00 | | |
| 7/21/2017 | Matthew G Manders | Insider | Sell | 24,357 | $175.01 | $4,262,718.57 | 46,256 | |
| 6/19/2017 | David Cordani | CEO | Sell | 153,168 | $170.20 | $26,069,193.60 | 421,162 | |
| 6/14/2017 | Michael W Triplett | Insider | Sell | 1,439 | $166.89 | $240,154.71 | 26,199 | |
| 6/6/2017 | Mary T Hoeltzel | VP | Sell | 500 | $166.70 | $83,350.00 | 2,449 | |
| 6/5/2017 | Jason D Sadler | Insider | Sell | 1,727 | $164.59 | $284,246.93 | 34,504 | |
| 6/2/2017 | Matthew G Manders | Insider | Sell | 6,000 | $165.00 | $990,000.00 | 33,799 | |
| 5/24/2017 | Lisa R Bacus | EVP | Sell | 11,455 | $161.57 | $1,850,784.35 | 24,753 | |
| 5/17/2017 | Nicole S Jones | EVP | Sell | 20,312 | $160.04 | $3,250,732.48 | 44,737 | |
| 4/24/2017 | Jane E. Md Henney | Director | Sell | 600 | $156.92 | $94,152.00 | | |
| 4/10/2017 | Jason D Sadler | Insider | Sell | 4,213 | $152.01 | $640,418.13 | 36,231 | |
| 2/27/2017 | David Cordani | CEO | Sell | 43,637 | $147.78 | $6,448,675.86 | 306,194 | |
| 2/27/2017 | Matthew G Manders | Insider | Sell | 8,309 | $146.54 | $1,217,600.86 | 39,799 | |
| 2/27/2017 | Thomas A Mccarthy | CFO | Sell | 4,464 | $146.54 | $654,154.56 | 80,531 | |
| 12/20/2016 | Jason D Sadler | Insider | Sell | 2,000 | $138.10 | $276,200.00 | 32,019 | |
| 11/7/2016 | John M Murabito | EVP | Sell | 58,822 | $125.09 | $7,358,043.98 | 115,109 | |
| 10/31/2016 | Jason D Sadler | Insider | Sell | 4,000 | $121.80 | $487,200.00 | 34,019 | |
| 8/17/2016 | Mary T Hoeltzel | VP | Sell | 500 | $132.28 | $66,140.00 | 4,017 | |
| 12/8/2015 | Isaiah Harris Jr | Chairman | Sell | 333 | $137.00 | $45,621.00 | 13,500 | |
| 11/16/2015 | Herbert A. Fritch | insider | Sell | 40,157 | $133.18 | $5,348,109.26 | 274,545 | |
| 10/15/2015 | Herbert A. Fritch | insider | Sell | 39,202 | $136.66 | $5,357,345.32 | 279,313 | |
| 9/15/2015 | Herbert A. Fritch | insider | Sell | 39,174 | $139.66 | $5,471,040.84 | 283,125 | |
| 8/17/2015 | Herbert A Fritch | Insider | Sell | 38,489 | $144.36 | $5,556,272.04 | | |
| 7/15/2015 | Herbert A Fritch | Insider | Sell | 37,918 | $155.96 | $5,913,691.28 | | |
| 6/15/2015 | Herbert A Fritch | Insider | Sell | 38,045 | $145.15 | $5,522,231.75 | | |
| 6/8/2015 | Isaiah Harris Jr | Chairman | Sell | 319 | $139.48 | $44,494.12 | | |
| 4/15/2015 | Herbert A Fritch | Insider | Sell | 38,080 | $132.99 | $5,064,259.20 | | |
| 3/16/2015 | Herbert A Fritch | Insider | Sell | 38,377 | $124.40 | $4,774,098.80 | | |
| 3/9/2015 | Isaiah Harris Jr | Chairman | Sell | 369 | $120.64 | $44,516.16 | | |
| 3/2/2015 | Nicole S Jones | EVP | Sell | 8,659 | $121.88 | $1,055,358.92 | | |
| 2/10/2015 | Mary T Hoeltzel | CAO | Sell | 6,805 | $113.29 | $770,938.45 | | |
| 1/15/2015 | Herbert A Fritch | Insider | Sell | 35,864 | $107.04 | $3,838,882.56 | | |
| 12/15/2014 | Herbert A Fritch | Insider | Sell | 35,929 | $101.67 | $3,652,901.43 | | |
| 12/8/2014 | Isaiah Harris Jr | Chairman | Sell | 437 | $104.60 | $45,710.20 | | |
| 12/1/2014 | John M Murabito | EVP | Sell | 12,000 | $102.76 | $1,233,120.00 | | |
| 9/10/2014 | Jane E Md Henney | Director | Sell | 475 | $95.98 | $45,590.50 | | |
| 8/18/2014 | Jason D Sadler | Insider | Sell | 11,000 | $93.02 | $1,023,220.00 | | |
| 8/1/2014 | Isaiah Harris Jr | Chairman | Sell | 1,066 | $90.22 | $96,174.52 | | |
| 6/13/2014 | Thomas A Mccarthy | CFO | Sell | 7,206 | $90.26 | $650,413.56 | | |
| 6/12/2014 | Nicole S Jones | EVP | Sell | 1,882 | $91.02 | $171,299.64 | | |
| 6/11/2014 | John M Murabito | EVP | Sell | 17,519 | $91.25 | $1,598,608.75 | | |
| 6/10/2014 | David Cordani | CEO | Sell | 133,523 | $89.73 | $11,981,018.79 | | |
| 6/2/2014 | David D Guilmette | Insider | Sell | 6,591 | $90.19 | $594,442.29 | | |
| 5/13/2014 | Jason Sadler | Insider | Sell | 6,145 | $88.50 | $543,832.50 | 20,879 | |
| 5/12/2014 | Matthew Manders | Insider | Sell | 9,905 | $87.79 | $869,559.95 | 51,736 | |
| 5/8/2014 | Jason Sadler | Insider | Sell | 7,810 | $85.59 | $668,457.90 | 27,024 | |
| 5/7/2014 | Mary Hoeltzel | CAO | Sell | 3,000 | $85.00 | $255,000.00 | 1,691 | |
| 3/14/2014 | John Murabito | EVP | Sell | 29,843 | $76.70 | $2,288,958.10 | 101,810 | |
| 3/14/2014 | Mary Hoeltzel | CAO | Sell | 5,333 | $77.72 | $414,480.76 | 1,691 | |
| 9/12/2013 | Nicole Jones | EVP | Sell | 1,530 | $82.35 | $125,995.50 | 5,337 | |
| 9/6/2013 | John M Murabito | EVP | Sell | 24,333 | $81.07 | $1,972,676.31 | | |
| 8/16/2013 | Jason Sadler | Insider | Sell | 13,261 | $77.81 | $1,031,838.41 | 22,189 | |
| 8/14/2013 | Mary Hoeltzel | CAO | Sell | 8,664 | $78.26 | $678,044.64 | 1,979 | |
| 8/7/2013 | John Murabito | EVP | Sell | 78,589 | $77.89 | $6,121,297.21 | 143,546 | |
| 6/13/2013 | David Cordani | CEO | Sell | 58,705 | $68.63 | $4,028,924.15 | | |
| 6/12/2013 | Matthew G Manders | Insider | Sell | 36,868 | $68.75 | $2,534,675.00 | | |
| 6/12/2013 | Nicole S Jones | EVP | Sell | 15,306 | $70.08 | $1,072,644.48 | | |
| 6/5/2013 | Isaiah Harris Jr | Chairman | Sell | 5,312 | $67.40 | $358,028.80 | | |
| 3/11/2013 | Mary T Hoeltzel | CAO | Sell | 5,712 | $60.50 | $345,576.00 | | |
| 3/6/2013 | Eric C Wiseman | Director | Buy | 4,200 | $59.30 | $249,060.00 | | |
(Data available from 1/1/2013 forward)
Cigna (NYSE CI) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | UBS Reaffirms Buy Rating for Cigna (CI)
www.americanbankingnews.com - April 20 at 5:52 PM |
 | Justice Deparment to review Cigna's acquisition of Express Scripts
www.bizjournals.com - April 19 at 9:39 AM |
| Cigna (CI) to Post FY2018 Earnings of $13.00 Per Share, Leerink Swann Forecasts
www.americanbankingnews.com - April 18 at 8:38 AM |
| Cigna (CI) to Post Q1 2018 Earnings of $3.45 Per Share, Leerink Swann Forecasts
www.americanbankingnews.com - April 17 at 6:12 AM |
| Cigna (CI) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - April 16 at 1:21 PM |
| Cigna (CI) Upgraded by ValuEngine to "Buy"
www.americanbankingnews.com - April 15 at 10:34 PM |
| Cigna (CI) Cut to Buy at BidaskClub
www.americanbankingnews.com - April 15 at 12:04 AM |
 | Yahoo Finance Live: Midday Movers - Apr 12th, 2018
finance.yahoo.com - April 14 at 9:30 AM |
| Cigna (CI) Expected to Announce Quarterly Sales of $11.04 Billion
www.americanbankingnews.com - April 13 at 4:50 AM |
 | Express Scripts: Heads (Cigna Buyout) Or Tails (Go Solo), Investors Can Win Either Way
seekingalpha.com - April 12 at 4:37 PM |
| Cigna (CI) Rating Reiterated by Royal Bank of Canada
www.americanbankingnews.com - April 12 at 1:15 PM |
| Brokerages Expect Cigna (CI) to Post $3.39 Earnings Per Share
www.americanbankingnews.com - April 11 at 3:14 AM |
 | Cigna Corporation's First Quarter 2018 Earnings Release Details
www.businesswire.com - April 5 at 4:31 PM |
| Cigna Corporation’s First Quarter 2018 Earnings Release Details
finance.yahoo.com - April 5 at 4:31 PM |
| America's Favorite TV Doctors of America Are Now On-Call
www.businesswire.com - April 5 at 9:14 AM |
| Cigna (CI) Given Consensus Recommendation of "Buy" by Analysts
www.americanbankingnews.com - April 4 at 1:47 PM |
| Zacks Investment Research Lowers Cigna (CI) to Sell
www.americanbankingnews.com - April 4 at 11:15 AM |
 | Buyout Target Express Scripts Has 30%-Plus Upside
www.barrons.com - April 3 at 4:39 PM |
| Express Scripts: Is There Any Logic Behind The Sell-Off?
seekingalpha.com - April 3 at 4:39 PM |
| [$$] Buyout Target Express Scripts Has 30%-Plus Upside
finance.yahoo.com - April 3 at 4:39 PM |
| Walmart Eyes Growth Avenues—Healthcare Could Be One
finance.yahoo.com - April 3 at 9:37 AM |
 | Cigna's CEO told us how his company's $67 billion deal for Express Scripts represents an 'evolution in the marketplace ...
www.businessinsider.com - April 2 at 4:36 PM |
| Leerink's Takeaways From CNBC's 'Healthy Returns' Conference
finance.yahoo.com - March 31 at 4:32 PM |
| Trump makes a house call to replace Veterans Affairs Secretary
finance.yahoo.com - March 31 at 4:32 PM |
| CIGNA (CI) Raised to Buy at ValuEngine
www.americanbankingnews.com - March 31 at 3:20 PM |
| How local health insurers are battling the opioid crisis
www.bizjournals.com - March 30 at 4:37 PM |
| The biggest healthcare mergers of the year shouldn't happen — period
www.businessinsider.com - March 29 at 9:47 AM |
| Cigna Facing More Declines
finance.yahoo.com - March 28 at 4:29 PM |
| Cigna Says It Reduced Opioid Use By 25%
finance.yahoo.com - March 28 at 9:24 AM |
| Is Cigna Corporation’s (NYSE:CI) ROE Of 16.19% Sustainable?
finance.yahoo.com - March 28 at 9:24 AM |
| Cigna's Partnership with Physicians Successfully Reduces Opioid Use by 25 Percent – One Year Ahead of Goal
finance.yahoo.com - March 28 at 9:24 AM |
| CIGNA Co. (CI) Expected to Post Q1 2018 Earnings of $3.51 Per Share
www.americanbankingnews.com - March 28 at 6:34 AM |
| $11.01 Billion in Sales Expected for CIGNA Co. (CI) This Quarter
www.americanbankingnews.com - March 27 at 8:26 AM |
| CIGNA Co. Forecasted to Earn Q4 2018 Earnings of $2.47 Per Share (CI)
www.americanbankingnews.com - March 27 at 7:48 AM |
| Financial Comparison: CIGNA (CI) and Zurich Insurance Group (ZURVY)
www.americanbankingnews.com - March 24 at 7:33 PM |
| Healthcare Reform, Top Down And Bottom Up
seekingalpha.com - March 24 at 4:57 PM |
| /DISREGARD RELEASE: Kahn Swick & Foti, LLC/
finance.yahoo.com - March 21 at 4:48 PM |
| The Zacks Analyst Blog Highlights: UnitedHealth, Morgan Stanley, Anheuser-Busch, Cigna and Intuitive Surgical
finance.yahoo.com - March 21 at 10:04 AM |
| Video: Jim Cramer on What's Next for Cigna and Express Scripts
finance.yahoo.com - March 20 at 4:40 PM |
| Upside buying in Cigna and this materials stock
finance.yahoo.com - March 20 at 4:40 PM |
| Zacks Investment Research Downgrades CIGNA (CI) to Hold
www.americanbankingnews.com - March 20 at 11:03 AM |
| UnitedHealth Group’s Recent Stock Performance
finance.yahoo.com - March 19 at 10:11 AM |
| CIGNA (CI) Receives New Coverage from Analysts at Sanford C. Bernstein
www.americanbankingnews.com - March 18 at 10:24 AM |
 | Spartanburg Regional Healthcare System's contract with Cigna is ending
www.msn.com - March 16 at 4:43 PM |
 | BRIEF-Cigna Says Jane Henney, Informed Co, Of Her Intention To Not Seek Re-Election As A Director
www.reuters.com - March 16 at 4:43 PM |
| Stocks are selling off today on the huge Retail Sales miss: NYSE trader
finance.yahoo.com - March 16 at 4:43 PM |
| How to Screen for Classic Value Stocks
finance.yahoo.com - March 15 at 10:28 AM |
| A.M. Best Places Credit Ratings of Cigna Corporation and Its Insurance Subsidiaries Under Review With Negative Implications
finance.yahoo.com - March 13 at 4:50 PM |
| Cigna Enters Voice Control Space, Launching “Answers by Cigna” Skill for Amazon Alexa
finance.yahoo.com - March 13 at 11:05 AM |
| WeissLaw LLP Investigates Express Scripts Holding Co. Acquisition
finance.yahoo.com - March 12 at 4:35 PM |
Cigna (NYSE:CI) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Cigna (NYSE:CI) Income Statement, Balance Sheet and Cash Flow Statement
Cigna (NYSE CI) Stock Chart for Sunday, April, 22, 2018
Loading chart…
